Small Excerpt
The international emphasis is now single-minded towards developing a vaccine as soon as possible under the assumption that it will protect its recipients from acquiring symptoms of illness. There remain many controversies over whether or not such a vaccine will be effective.
Dr. Peter Doshi, Associate Editor for the British Medical Journal, recently published an article stating an observation that will surely upset vaccine advocates.  “None of the trials currently underway,” Doshi writes, “are designed to detect a reduction in any serious outcome such as hospitalizations, intensive care use, deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus.”
 Please allow his statement to sink in for a moment. In other words, based upon the trials underway, whether these vaccines will protect you or others is completely unknown.
The standard PCR test, the most relied upon diagnostic tool, is non-specific for detecting the Covid-19 strain. Other tests are terribly inaccurate. You may have had a small cold from any one of many coronavirus strains months ago and still test PCR-positive and be ruled as having contracted Covid-19. Of course the more tests performed will result in an increase in positive outcomes, especially among those who are asymptomatic, mildly so, or may have contracted it in the past but are no longer infected. If everyone were tested for the herpes virus, for example, we would have a herpes pandemic that would dwarf Covid-19 by the mere policy of widespread testing. But PCR was never intended for clinical use or diagnostics. The figures being broadcasted, therefore, do not represent reliable data to conclude there is a real present danger. But for people, if they test positive, even with a grossly inaccurate test, they will believe they are infected and could develop full-blown symptoms and die. Indeed, for a much smaller segment of people this is true, just as it is for the flu and other infectious respiratory illnesses.